Investor Relations

Investor Relations

Aradigm's Scientific Advisory Board is a highly regarded team of scientific experts who help the Company with strategic input into the development of treatments for severe respiratory disease, hormonal and metabolic disorders, and in pharmaceutical development and pulmonary drug delivery in general. The group assists the company on a variety of issues related to potential product applications, product development paths and clinical testing.

Peter R. Byron Ph.D.
Medical College of Virginia, Virginia Commonwealth University.
Area of expertise: Aerosol Science/ Pharmaceutics
Stephen J. Farr Ph.D.
Zogenix, Inc.
Area of expertise: Pulmonary Delivery/Pharmaceutics
Tunde Otulana M.D.
Boehringer Ingelheim
Area of expertise: Pulmonary Medicine, Regulatory Science
Adam Wanner M.D.
University of Miami
Area of expertise: Chronic Obstructive Pulmonary Disease (COPD)

In addition to this Scientific Advisory Board, the company also engages other scientific and medical experts to assist on issues specific to particular indications and programs.

CONTACT NEWS & EVENTS LEGAL SITE MAP ©2019 Aradigm Corporation. All Rights Reserved.